No abstract available
MeSH terms
-
Acute Disease
-
Adolescent
-
Anti-Asthmatic Agents / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Asthma / drug therapy*
-
Biological Products / therapeutic use*
-
Child
-
Humans
-
Omalizumab / therapeutic use
-
Treatment Outcome
Substances
-
Anti-Asthmatic Agents
-
Antibodies, Monoclonal, Humanized
-
Biological Products
-
Omalizumab
-
benralizumab
-
mepolizumab